Am
J Epidemiol 1993 Sep 15;138(6):395-406
Old age and race as determinants of initiation of glaucoma therapy.
Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Choodnovskiy I, Avorn J.
Program for the Analysis of Clinical Strategies, Brigham and Women's
Hospital, Harvard Medical School, Boston, MA 02115.
Demographic differences in the prevalence of blindness may be partly
due to undertreatment of susceptible population subgroups. The authors
examined the relation of age, race, and other demographic characteristics
with initiation of treatment for glaucoma and compared treatment rates
with expected rates based on known disease prevalence. Data were from
Medicaid enrollees aged 65-99 years in New Jersey between March 1981 and
February 1990. Based on review of all claims for prescription medications
and laser and incisional surgery, there were 6,173 cases with at least
6 months of documented system eligibility before their initial treatment
for glaucoma. The overall rate of new treatment was 11.5 cases per 1,000
person-years, and increased throughout the 1980s. The age-adjusted relative
rate of new treatment was 1.58 times higher in blacks compared with whites;
however, this was less than half the relative rate expected based on estimated
relative incidence rates. Similarly, enrollees aged 70-99 years had only
7% to 27% higher treatment rates than those aged 65-69 years, substantially
less than expected. Treatment for glaucoma was also less likely to be
initiated in nursing home residents, compared with those living in the
community. Blacks and the very old are much less likely to have treatment
for glaucoma initiated than would be predicted based on the magnitude
of disease burden in these populations.
PMID: 8213745 [PubMed - indexed for MEDLINE]